Related Experiment Video
Updated: Jun 23, 2026

08:53
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
Rescue of coagulation factor VII function by the U1+5A snRNA
Mirko Pinotti1, Dario Balestra, Lara Rizzotto
1Department of Biochemistry, University of Ferrara, Italy. pnm@unife.it
Blood
|April 24, 2009
Summary
Engineered U1 small nuclear RNA (U1+5a) partially restored functional coagulation factor VII (FVII) protein levels. This offers potential therapeutic strategies for bleeding disorders caused by FVII mutations.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- A specific mutation (9726+5G>A) impairs coagulation factor VII (FVII) mRNA processing.
- Engineered U1 small nuclear RNA (U1+5a) previously showed partial rescue of FVII mRNA processing in minigene studies.
Purpose of the Study:
- To evaluate the effect of U1+5a on FVII protein function.
- To assess the therapeutic potential of U1+5a for FVII-related bleeding disorders.
Main Methods:
- A full-length splicing-competent FVII construct (pSCFVII-wt) was created.
- COS-1 cells were transfected with wild-type or mutated FVII constructs, with or without pU1+5a.
- Functional FVII protein levels were measured in cell culture medium.
Main Results:
- The 9726+5G>A mutation abolished functional FVII secretion.
- Cotransfection with pU1+5a partially rescued FVII splicing and protein biosynthesis.
- A dose-dependent increase in functional FVII was observed, reaching 5.0 +/- 2.8 ng/mL (9.5% of wild-type) with excess pU1+5a.
Conclusions:
- U1-snRNA can mediate the rescue of donor splice sites at the protein level.
- These findings highlight the therapeutic implications of U1-snRNA for bleeding disorders.
- Even small increases in functional FVII levels may benefit patients.
More Related Videos
Related Concept Videos
RNA-seq
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

